Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial
Article Information
vol. 33 no. 5 983-990
PubMed
Published By
Print ISSN
Online ISSN
History
- Received July 29, 2009
- Accepted February 7, 2010
- Published in print April 28, 2010.
Copyright & Usage
© 2010 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
Author Information
- Matthew C. Riddle, MD1,
- Walter T. Ambrosius, PHD2,
- David J. Brillon, MD3,
- John B. Buse, MD, PHD4,
- Robert P. Byington, MPH, PHD2,
- Robert M. Cohen, MD5,
- David C. Goff Jr., MD, PHD2,
- Saul Malozowski, MD, PHD6,
- Karen L. Margolis, MD, MPH7,
- Jeffrey L. Probstfield, MD8,
- Adrian Schnall, MD9,
- Elizabeth R. Seaquist, MD10 and
- for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Investigators*
- 1Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health and Science University, Portland, Oregon;
- 2Wake Forest University School of Medicine, Winston-Salem, North Carolina;
- 3Weill Cornell Medical College of Cornell University, New York, New York;
- 4University of North Carolina School of Medicine, Chapel Hill, North Carolina;
- 5University of Cincinnati College of Medicine, Cincinnati, Ohio;
- 6National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland;
- 7Health Partners Research Foundation, Minneapolis, Minnesota;
- 8University of Washington School of Medicine, Seattle, Washington;
- 9Case Western Reserve University School of Medicine, Cleveland, Ohio;
- 10University of Minnesota School of Medicine, Minneapolis, Minnesota.
- Corresponding author: Matthew C. Riddle, riddlem{at}ohsu.edu.
Statistics from Altmetric.com
Article usage
In this Issue
May 2010, 33(5)
Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial
